Skip to main content
Clinical Trials/NCT01950338
NCT01950338
Completed
Not Applicable

CHANGES IN SPASTICITY, WIDESPREAD PRESSURE PAIN SENSITIVITY, AND BAROPODOMETRY AFTER DRY NEEDLING IN STROKE PATIENTS

Universidad Rey Juan Carlos1 site in 1 country34 target enrollmentJanuary 2013
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Universidad Rey Juan Carlos
Enrollment
34
Locations
1
Primary Endpoint
Changes in spasticity before and after the intervention
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Stroke is the leading cause of physical disability, particularly due to the presence of spasticity. Different needling techniques, including the use of Botulinum Toxin A are proposed for the management of spasticity. The presence of spasticity in the lower extremity implies several impairments for standing and walking inducing high disability. No study has investigated the effects of deep dry needling inserted into the targeted spastic musculature in patients with stroke. The investigators will conduct a randomized controlled trial investigating the effects of a single session of deep dry needling over the musculature of the leg on spasticity, widespread pressure pain sensitivity and plantar pressures (baropodometry) in individuals with chronic stroke. The investigators hypothesize that patients receiving a single session of dry needling would exhibit a greater reduction in spasticity and pressure sensitivity than those who will not receive the intervention.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
October 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

César Fernández-de-las-Peñas

PROFESSOR

Universidad Rey Juan Carlos

Eligibility Criteria

Inclusion Criteria

  • First-ever unilateral stroke;
  • hemiplegia resulting from stroke;
  • unilateral equinovarus gait with independent walk;
  • able to ambulate without supporting devices.

Exclusion Criteria

  • recurrent stroke;
  • previous treatment with nerve blocks, motor point injections with neurolytic agents for spasticity at any time, or with BTX-A in the previous 6 months
  • not independent in the basic activities of daily living
  • severe cognitive deficits;
  • progressive or severe neurologic diseases;
  • fear to needles;
  • any contraindication for dry needling, e.g., anticoagulants, infections, bleeding, or psychotic.

Outcomes

Primary Outcomes

Changes in spasticity before and after the intervention

Time Frame: Baseline and immediate after the inetrvention

Spasticity in the affected ankle joint will be evaluated with the Modified Modified Ashworth Scale (MMAS). The examiner passively will move the ankle in dorsal-flexion direction, back and forth at least 5 times and will evaluate the degree of resistance to the movement on a scale from 0-4. This outcome will take 1 minute approximately.

Secondary Outcomes

  • Changes in pressure pain sensitivity before and after the intervention(Baseline and immediate after the inetrvention)
  • Changes in baropodometry outcomes before and after the intervention(Baseline and immediate after the inetrvention)

Study Sites (1)

Loading locations...

Similar Trials